I could see this at $18 - $36+ in time. 1.6 bil
Post# of 72440
1.6 billion transaction will bolster Lilly's clinical portfolio with ARMO's lead immuno-oncology asset, pegilodecakin, which is being studied in multiple tumor types
https://finance.yahoo.com/news/lilly-announce...00916.html